These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30290291)

  • 21. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
    Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
    Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.
    Mamakwa S; Kahan M; Kanate D; Kirlew M; Folk D; Cirone S; Rea S; Parsons P; Edwards C; Gordon J; Main F; Kelly L
    Can Fam Physician; 2017 Feb; 63(2):137-145. PubMed ID: 28209683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
    Fiellin DA; Pantalon MV; Chawarski MC; Moore BA; Sullivan LE; O'Connor PG; Schottenfeld RS
    N Engl J Med; 2006 Jul; 355(4):365-74. PubMed ID: 16870915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
    West R; Mikel C; Hofilena D; Guevara M
    Drug Alcohol Depend; 2018 Dec; 193():183-191. PubMed ID: 30391868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants.
    Wilcox CE; Bogenschutz MP; Nakazawa M; Woody G
    Addict Behav; 2013 Oct; 38(10):2568-74. PubMed ID: 23811060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program.
    Campbell MD; Kolodner G; Spencer RA; DuPont RL
    J Addict Dis; 2016; 35(4):315-324. PubMed ID: 26757093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
    Fiellin DA; Schottenfeld RS; Cutter CJ; Moore BA; Barry DT; O'Connor PG
    JAMA Intern Med; 2014 Dec; 174(12):1947-54. PubMed ID: 25330017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder.
    Pytell JD; Whitley P; Passik SD; Bundy WL; Dawson E; Saloner B
    JAMA Psychiatry; 2023 May; 80(5):459-467. PubMed ID: 36947029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
    Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE
    J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states.
    Hammerslag L; Talbert J; Donohue JM; Sharbaugh M; Ahrens K; Allen L; Austin AE; Gordon AJ; Jarlenski M; Kim JY; Mohamoud S; Tang L; Burns M;
    Drug Alcohol Depend; 2023 Sep; 250():110875. PubMed ID: 37413960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
    Ling W; Hillhouse MP; Saxon AJ; Mooney LJ; Thomas CM; Ang A; Matthews AG; Hasson A; Annon J; Sparenborg S; Liu DS; McCormack J; Church S; Swafford W; Drexler K; Schuman C; Ross S; Wiest K; Korthuis PT; Lawson W; Brigham GS; Knox PC; Dawes M; Rotrosen J
    Addiction; 2016 Aug; 111(8):1416-27. PubMed ID: 26948856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.
    Sullivan LE; Moore BA; O'Connor PG; Barry DT; Chawarski MC; Schottenfeld RS; Fiellin DA
    Am J Addict; 2010; 19(1):53-8. PubMed ID: 20132122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
    Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
    Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician Renewal of Chronically Prescribed Controlled Substances Based on Urine Drug Test Results.
    Hosain F; Lee J; Ata A; Bhullar RK; Chang AK
    J Prim Care Community Health; 2019; 10():2150132719883632. PubMed ID: 31646927
    [No Abstract]   [Full Text] [Related]  

  • 40. Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada.
    Young S; Hayashi K; Grant C; Milloy MJ; DeBeck K; Wood E; Fairbairn N
    Drug Alcohol Depend; 2021 Nov; 228():109006. PubMed ID: 34509737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.